The effect of psyllium supplementation on blood pressure: a systematic review and meta-analysis of randomized controlled trials
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Global incidence of hypertension is estimated to be, in excess of, one billion people, and given the efficacy of soluble dietary fibers, in particular, Psyllium, to positively impact blood pressure in patients with hypertension, it is of clinical importance that consensus on its supplementation be established. Therefore, the aim of the study was systematically review and meta-analyze the effect of psyllium supplementation on blood pressure of hypertensive patients in randomized controlled trials. Methods: We searched six universal databases including; Pubmed/Medline, Ovid, Cochrane Library, Google Scholar, Embase, and Scopus until November 2018. Both combined and stratified analyzes were conducted. A fixed-effects or random- effects model was used to assess the mean effect sizes. Results: An eventual 11 trials with 592 participants were considered as eligible for inclusion in the present meta-analysis. The meta-analysis revealed a significant reduction of 2.04 mmHg in systolic blood pressure (weighted mean difference, –2.04; 95% confidence interval, –2.82 to –1.63; p < 0.001). Whilst meta-regression highlighted that the hypotensive effect of psyllium was stronger in subjects with higher baseline blood pressure. Conclusions: Given the overarching benefits and lack of reported side effects, particularly for hypertensive patients, health care providers and clinicians should consider the use of psyllium supplementation for the treatment or abatement of hypertension, or hypertensive symptoms.
Abstract
Background/Aims: Global incidence of hypertension is estimated to be, in excess of, one billion people, and given the efficacy of soluble dietary fibers, in particular, Psyllium, to positively impact blood pressure in patients with hypertension, it is of clinical importance that consensus on its supplementation be established. Therefore, the aim of the study was systematically review and meta-analyze the effect of psyllium supplementation on blood pressure of hypertensive patients in randomized controlled trials. Methods: We searched six universal databases including; Pubmed/Medline, Ovid, Cochrane Library, Google Scholar, Embase, and Scopus until November 2018. Both combined and stratified analyzes were conducted. A fixed-effects or random- effects model was used to assess the mean effect sizes. Results: An eventual 11 trials with 592 participants were considered as eligible for inclusion in the present meta-analysis. The meta-analysis revealed a significant reduction of 2.04 mmHg in systolic blood pressure (weighted mean difference, –2.04; 95% confidence interval, –2.82 to –1.63; p < 0.001). Whilst meta-regression highlighted that the hypotensive effect of psyllium was stronger in subjects with higher baseline blood pressure. Conclusions: Given the overarching benefits and lack of reported side effects, particularly for hypertensive patients, health care providers and clinicians should consider the use of psyllium supplementation for the treatment or abatement of hypertension, or hypertensive symptoms.
참고문헌 (54)
- Beilin LJ, "Vegetarian and other complex diets, fats, fiber, and hypertension", Am J Clin Nutr, 59, pp.1130S~1135S (1994)
- He J, "Effect of dietary fiber and protein intake on blood pressure : a review of epidemiologic evidence", Clin Exp Hypertens, 21, pp.785~796 (1999)
- Rouse IL, "Blood-pressure-lowering effect of a vegetarian diet : controlled trial in normotensive subjects", Lancet, 1, pp.5~10 (1983)
- Forman D, "Cardiovascular disease : optimal approaches to risk factor modification of diet and lifestyle", Curr Treat Options Cardiovasc Med, 8, pp.47~57 (2006)
- Pearson TA, "American Heart Association guide for improving cardiovascular health at the community level : a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science", Circulation, 107, pp.645~651 (2003)
- Streppel MT, "Dietary fiber and blood pressure : a meta-analysis of randomized placebo-controlled trials", Arch Intern Med, 165, pp.150~156 (2005)
- He J, "Dietary macronutrients and blood pressure in southwestern China", J Hypertens, 13, pp.1267~1274 (1995)
- Stamler J, "Relationships of dietary variables to blood-pressure (BP): findings of the Multiple Risk Factor Intervention Trial (MRFIT)", Circulation, 85, pp.867~ (1992)
- Nishida C, "The joint WHO", FAO expert consultation on diet, nutrition and the prevention of chronic diseases : process, product and policy implications, 2004, pp.7, 245~250
- Brown L, "Cholesterol-lowering effects of dietary fiber : a meta-analysis", Am J Clin Nutr, 69, pp.30~42 (1999)
- Eastwood MA, "Dietary fibre", Lancet, 2, pp.202~206 (1983)
- Howlett JF, "The definition of dietary fiber: discussions at the Ninth Vahouny Fiber Symposium: building scientific agreement", Food Nutr Res, pp.54~ (2010)
- Taneja A, "Effect of incorporation of isabgol husk in a low fibre diet on faecal excretion and serum levels of lipids in adolescent girls", Eur J Clin Nutr, 43, pp.197~202 (1989)
- Dennison BA, "Randomized, double-blind, placebo-controlled, two-period crossover clinical trial of psyllium fiber in children with hypercholesterolemia", J Pediatr, 123, pp.24~29 (1993)
- Glassman M, "Treatment of type IIa hyperlipidemia in childhood by a simplified American Heart Association diet and fiber supplementation", Am J Dis Child, 144, pp.973~976 (1990)
- Delargy HJ, "Effects of amount and type of dietary fibre(soluble and insoluble)on short-term control of appetite", Int J Food Sci Nutr, 48, pp.67~77 (1997)
- Racette SB, "Obesity : overview of prevalence, etiology, and treatment", Phys Ther, 83, pp.276~288 (2003)
- Hense HW, "Once at risk--forever at risk? The long-term impact of cardiovascular risk factors on death", Eur J Epidemiol, 19, pp.409~410 (2004)
- Sepanlou SG, "Disability-Adjusted Life-Years (DALYs) for 315 diseases and injuries and Healthy Life Expectancy (HALE) in Iran and its neighboring countries, 1990-2015: findings from Global Burden of Disease Study 2015", Arch Iran Med, 20, pp.403~418 (2017)
- Moher D, "Preferred reporting items for systematic reviews and meta-analyses : the PRISMA statement", Ann Intern Med, 151, pp.264~269 (2009)
- Green S, "Cochrane Handbook for Systematic Reviews of Interventions" (2005), John Wiley &Sons Ltd
- Jadad AR, "Assessing the quality of reports of randomized clinical trials : is blinding necessary", Control Clin Trials, 17, pp.1~12 (1996)
- Hozo SP, "Estimating the mean and variance from the median, range, and the size of a sample", BMC Med Res Methodol, 5, pp.13~ (2005)
- Gopalakrishnan S, "Systematic reviews and meta-analysis : understanding the best evidence in primary healthcare", J Family Med Prim Care, 2, pp.9~14 (2013)
- Burke V, "Dietary protein and soluble fiber reduce ambulatory blood pressure in treated hypertensives", Hypertension, 38, pp.821~826 (2001)
- Jenkins DJ, "Effect of psyllium in hypercholesterolemia at two monounsaturated fatty acid intakes", Am J Clin Nutr, 65, pp.1524~1533 (1997)
- Cochrane Collaboration, "Cochrane Handbook for Systematic Reviews of Interventions" (2008), Wiley
- Anderson JW, "Cholesterol-lowering effects of psyllium hydrophilic mucilloid for hypercholesterolemic men", Arch Intern Med, 148, pp.292~296 (1988)
- Asghar J, "Biostatistical analysis of morbidity & mortality due to myocardial infarction and its prevention by hypolipidemic drug regimen", Pak J Med Health Sci, 5, pp.445~449 (2011)
- Bell LP, "Cholesterol-lowering effects of psyllium hydrophilic mucilloid. Adjunct therapy to a prudent diet for patients with mild to moderate hypercholesterolemia", JAMA, 261, pp.3419~3423 (1989)
- Cicero AF, "Different effect of psyllium and guar dietary supplementation on blood pressure control in hypertensive overweight patients : a six-month, randomized clinical trial", Clin Exp Hypertens, 29, pp.383~394 (2007)
- Ghalandari H, "Comparison of two calorie-reduced diets of different carbohydrate and fiber contents and a simple dietary advice aimed to modify carbohydrate intake on glycemic control and inflammatory markers in type 2 diabetes: a randomized trial", Int J Endocrinol Metab, 16, pp.e12089~ (2017)
- Murad S, "Keep heart healthy by normalising body weight, blood pressure and weight reduction", Pak J Med Health Sci, 5, pp.228~231 (2011)
- Sartore G, "The effects of psyllium on lipoproteins in type II diabetic patients", Eur J Clin Nutr, 63, pp.1269~1271 (2009)
- Murray CJ, "Disability-adjusted life years(DALYs)for 291 diseases and injuries in 21 regions, 1990-2010 : a systematic analysis for the Global Burden of Disease Study 2010", Lancet, 380, pp.2197~2223 (2012)
- GBD 2015 Risk Factors Collaborators, "Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015", Lancet, 388, pp.1659~1724 (2016)
- Slavin JL, "Partially hydrolyzed guar gum : clinical nutrition uses", Nutrition, 19, pp.549~552 (2003)
- Grundy SM, "Clinical management of metabolic syndrome: report of the American Heart Association", National Heart, Lung, and Blood Institute, Circulation, pp.2004, 109[DOI]
- Whelton SP, "Effect of dietary fiber intake on blood pressure : a meta-analysis of randomized, controlled clinical trials", J Hypertens, 23, pp.475~481 (2005)
- Spiller GA, "CRC Handbook of Dietary Fiber in Human Nutrition" (2001), CRC press
- Bessesen DH, "The role of carbohydrates in insulin resistance", J Nutr, 131, pp.2782S~2786S (2001)
- Landsberg L, "Insulin-mediated sympathetic stimulation:role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why)", J Hypertens, 19, pp.523~528 (2001)
- Cleland SJ, "Insulin as a vascular hormone : implications for the pathophysiology of cardiovascular disease", Clin Exp Pharmacol Physiol, 25, pp.175~184 (1998)
- Coudray C, "Effects of dietary fibers on magnesium absorption in animals and humans", J Nutr, 133, pp.1~4 (2003)
- Greger JL, "Nondigestible carbohydrates and mineral bioavailability", J Nutr, 129, pp.1434S~1435S (1999)
- Wong JM, "Carbohydrate digestibility and metabolic effects", J Nutr, 137, pp.2539S~2546S (2007)
- Montero D, "Hemodynamic actions of insulin : beyond the endothelium", Front Physiol, 4, pp.389~ (2013)
- Schulman IH, "Vascular insulin resistance : a potential link between cardiovascular and metabolic diseases", Curr Hypertens Rep, 11, pp.48~55 (2009)
- Zhou MS, "Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension : role of nuclear factor kappa B activation", J Hypertens, 28, pp.527~535 (2010)
- Landin K, "Guar gum improves insulin sensitivity, blood lipids, blood pressure, and fibrinolysis in healthy men", Am J Clin Nutr, 56, pp.1061~1065 (1992)
- Chutkan R, "Viscous versus nonviscous soluble fiber supplements : mechanisms and evidence for fiber-specific health benefits", J Am Acad Nurse Pract, 24, pp.476~487 (2012)
- January CT, "2014 AHA", ACC, American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society, pp.J Am Coll Cardiol, 2014[DOI]
- Khan K, "The effect of viscous soluble fiber on blood pressure: a systematic review and meta-analysis of randomized controlled trials", Nutr Metab Cardiovasc Dis, 28, pp.3~13 (2018)
- Sterne JA, "Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis", J Clin Epidemiol, 54, pp.1046~1055 (2001)
